BERKELEY, CA -- (MARKET WIRE) -- 02/14/12 --
Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Dino Dina, M.D., Chief Executive Officer, will be presenting at the Citigroup 2012 Global Health Care Conference to be held February 27-29, and at the Cowen and Company 32nd Annual Health Care Conference being held March 5-7, 2012.
Event: Citigroup 2012 Global Health Care Conference
Date: Tuesday, February 28, 2012
Time: 8:30 AM (ET)
Place: Waldorf Astoria, New York, NY
Event: Cowen and Company 32nd Annual Health Care Conference
Date: Tuesday, March 6, 2012
Time: 10:00 AM (ET)
Place: The Boston Marriott Copley Place, Boston, MA
To access the live webcast and the subsequent archived recording of the presentations, please log onto Dynavax's website at http://investors.dynavax.com/newsevents.cfm.
About Dynavax
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit www.dynavax.com.
Contact:
Jennifer Lew
Vice President, Finance
510-665-7217
Email Contact
Source: Dynavax Technologies
News Provided by Acquire Media
